BBS student Eileen Ablondi is featured in a Harvard Medicine News article.

Cancer cells are often a mess of mutations. About 20 to 25 percent of cancers involve mutations in a complex of molecules called SWI/SNF. Yet drugs designed to block SWI/SNF activity haven’t always worked as expected.... Read more about One Punch Isn’t Enough